Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation

European Journal of Pediatrics

Volumn 166, Issue 8, 2007, Pages 785-788

  Schuetz, Catharina ^a   Hoenig, Manfred ^a   Schulz, Ansgar ^a   Lee Kirsch, Min Ae ^b   Roesler, Joachim ^b   Friedrich, Wilhelm ^a   Von Bernuth, Horst ^b,c  

^a UNIVERSITY OF ULM   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c IMAGINE INSTITUTE   (France)

Author keywords

Bone marrow transplantation; Cerebral lesions; Chronic granulomatous disease; Granuloma formation

Indexed keywords

AMPHOTERICIN B; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ITRACONAZOLE; METHOTREXATE; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ARTICLE; BLOOD GROUP KELL SYSTEM; BONE MARROW TRANSPLANTATION; BRAIN DAMAGE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; GENETIC ANALYSIS; GRAFT VERSUS HOST REACTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ASPERGILLOSIS; LUNG GRANULOMA; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

BONE MARROW TRANSPLANTATION; BRAIN DISEASES; CEREBRUM; CHILD; GENE DELETION; GENETIC MARKERS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250860147     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0317-7     Document Type: Article

References (18)

1. Agus S, Spektor S, Israel Z (2000) CNS granulomatosis in a child with chronic granulomatous disease. Br J Neurosurg 14:59-61
2. Alsultan A, Williams MS, Lubner S, Goldman FD (2006) Chronic granulomatous disease presenting with disseminated intracranial aspergillosis. Pediatr Blood Cancer 47:107-110
3. Brown JR, Goldblatt D, Buddle J, Morton L, Thrasher AJ (2003) Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 73:591-599
4. Fleischmann J, Church JA, Lehrer RI (1986) Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 291:334-341
5. Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, Noack D, Rae J, Winkelstein JA, Curnutte JT, Chanock SJ (1998) Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 102:2146-2155
6. Gardai S, Whitlock BB, Helgason C, Ambruso D, Fadok V, Bratton D, Henson PM (2002) Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J Biol Chem 277:5236-5246
7. Goldblatt D (2002) Current treatment options for chronic granulomatous disease. Expert Opin Pharmacother 3:857-863
8. Hadfield MG, Ghatak NR, Laine FJ, Myer EC, Massie FS, Kramer WM (1991) Brain lesions in chronic granulomatous disease. Acta Neuropathol (Berl) 81:467-470
9. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N (1997) Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89:1748-1753
10. Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI (2005) Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol 174:411-417
11. Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, Gahr M, Belohradsky BH (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687-693
12. Meischl C, Roos D (1998) The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol 19:417-434
13. Roesler J, Heyden S, Burdelski M, Schafer H, Kreth HW, Lehmann R, Paul D, Marzahn J, Gahr M, Rosen-Wolff A (1999) Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease. Exp Hematol 27:505-511
14. Roesler J, Koch A, Porksen G, von Bernuth H, Brenner S, Hahn G, Fischer R, Lorenz N, Gahr M, Rosen-Wolff A (2005) Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD). J Eval Clin Pract 11:513-521
15. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79:170-200
16. Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, Flood T, Landais P, Muller S, Ozsahin H, Passwell JH, Porta F, Slavin S, Wulffraat N, Zintl F, Nagler A, Cant A, Fischer A (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 100:4344-50
17. von Bernuth H, Knoechel B, Bergert R, Winkler U, Wendisch J, Hahn G, Rupprecht E, Roesler J, Gahr M (2003) Clinical presentation, diagnosis and therapy of granulomatous inflammations in patients with chronic granulomatous disease (CGD). Monatsschr Kinderheilkd 151:49-56
18. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169